Clofazimine (as component of XDR-TB regimen)
Treatment for Hiv Aids Extensively Drug Resistant Tuberculosis
Typical Dosage: 100mg daily or 300mg three times a week
Effectiveness
65%
Safety Score
62%
Clinical Trials
100
Participants
20K
Comparative Safety Scale(Higher is safer)
Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
62
DangerousModerateSafe
Treatment Details
Dosage Range
100mg daily or 300mg three times a week
Time to Effect
Contributes to regimen effect over months
Treatment Duration
Typically 18-24 months (as part of regimen)
Evidence Quality
MODERATENumber Needed to Harm (NNH)
15(Treat 15 patients to see 1 additional serious adverse event)
Confidence Score
85%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$800
Monitoring:$500
Side Effect Mgmt:$1,000
Total Annual:$2,300
Clofazimine (as component of XDR-TB regimen) Outcomes
for Hiv Aids Extensively Drug Resistant Tuberculosis
Efficacy Outcomes
Overall Effectiveness
+65%
Common Side Effects
Skin discoloration (reddish-brown to black)
+90%
Ichthyosis/dry skin
+50%
Gastrointestinal issues (abdominal pain, nausea, diarrhea)
+30%
QT prolongation
+3%
Active Clinical Trials
No active trials currently recruiting for this treatment
No active trials found in ClinicalTrials.gov